Evidence map›Paper›PMID 33255415›Full record

ArticleNanomaterials (Basel, Switzerland)2020

CeO

Martina Cotena, Mélanie Auffan, Stéphane Robert, Virginie Tassistro, Noémie Resseguier, Jérôme Rose, Jeanne Perrin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. In Vitro Co-Exposure to CeONanomaterials (Basel, Switzerland) · 2021
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Martina CotenaIMBE, CNRS, IRD, Avignon Université, Aix Marseille University, 13005 Marseille, France.
Mélanie AuffanCEREGE, Europole Arbois, BP 80, CNRS, IRD, INRAE, Coll France, Aix Marseille University, 13545 Aix en Provence, France.ORCID 0000-0003-4207-3526
Stéphane RobertAMUTICYT Core Facility, UMR1263, INSERM, INRAE, Aix Marseille University, 13005 Marseille, France.
Virginie TassistroIMBE, CNRS, IRD, Avignon Université, Aix Marseille University, 13005 Marseille, France.
Noémie ResseguierDepartment of Biostatistics and Public Health, La Timone Hospital, 13005 Marseille, France.ORCID 0000-0003-0816-4053
Jérôme RoseCEREGE, Europole Arbois, BP 80, CNRS, IRD, INRAE, Coll France, Aix Marseille University, 13545 Aix en Provence, France.
Jeanne PerrinIMBE, CNRS, IRD, Avignon Université, Aix Marseille University, 13005 Marseille, France.
Centre National de la Recherche Scientifique · FRInserm · FR

Funding

European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No713750. Additionally, it has been performed with the financial supports of the Regional Council of Provence- Alpes-Côte d'Azur and A*MIDEX ( No713750
6 · The paper itself

Abstract

Cerium dioxide nanomaterials (CeO

Indexed as

ageingcombustionDNA damagenanoparticlesNMs life cycleOxidative stressreproductive toxicity

Identifiers

PMID33255415
PMCPMC7760532
OpenAlexW3107803919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.